Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
An important feature of the development of many human and animal tumours is the appearance of pre-malignant benign lesions, some of which undergo further changes during progression to malignancy. Many of the currently accepted concepts of multi-stage carcinogenesis have been developed using an experimental model based on the chemical induction of tumours in mouse skin. In this system, many of the premalignant papillomas which arise are promoter-dependent, and appear to regress if promoter treatment is interrupted, whereas others progress to form autonomous benign lesions and, in some cases, malignant carcinomas. Although the number and nature of the events leading to malignancy are not known, DNA transfection experiments have led to the identification of several genes which may be qualitatively altered in tumour cells (see ref. 6 for review). We have previously shown that DNA from transplantable mouse skin carcinomas induced by chemical carcinogens has the ability to transform NIH/3T3 cells, and that the gene responsible for the transformation is an activated form of the mouse cellular Harvey-ras gene (c-rasH). We have now investigated the stage of carcinogenesis at which the proto-oncogene acquires transforming activity. We demonstrate that primary papillomas induced by chemical carcinogens in two different mouse strains have an activated c-rasH gene. This constitutes the first report of a benign tumour which contains DNA with detectable transforming activity. In addition, steady-state levels of c-rasH gene transcripts are elevated in the papillomas as compared with normal epidermis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, these G4 TERCÀ/À APC min mice exhibited a profound suppression of more advanced adenomatous lesions in association with significant intratumoral growth arrest and apoptosis (89).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“Quantitative analysis of mice with multiple intestinal neoplasia (min) provided further evidence that telomere shortening can dramatically impair tumor development in epithelial cells at specific stages in the malignant transformation process.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“In this APC min model, the addition of telomere dysfunction resulted in an increase in early neoplastic lesions probably due to chromosome instability resulting in increased loss of the remaining wild-type APC allele.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“The antitumor effects of telomere dysfunction resulted in dramatically increased survival in G4 TERCÀ/À APC min mice by preventing blood loss caused by gastrointestinal tract adenomas.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“Anaphase bridges, a hallmark of dysfunctional telomeres, are low in adenomas but increase substantially at the adenoma-carcinoma transition.Anaphase bridges become significantly more abundant at the pre-invasive and invasive colon cancer stages (89).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
Citations
Cites
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391
Mutation and Cancer: A Model for Human Carcinogenesis2
Moolgavkar, S. H., & Knudson, A. G. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1037 · Cited by 1,086
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
The Function and Mechanism of Promoters of Carcinogenesis
Boutwell, R. K., & Sivak, A. (1973) · CRC Critical Reviews in Toxicology · doi:10.3109/10408447309025704 · Cited by 746
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Cooper, G. M. (1982) · Science · doi:10.1126/science.6285471 · Cited by 606
A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer
Armitage, P., & Doll, R. (1957) · British Journal of Cancer · doi:10.1038/bjc.1957.22 · Cited by 555
Oncogenes in solid human tumours
Pulciani, S., Santos, E., Lauver, A. V., Long, L. K., Aaronson, S. A., & Barbacid, M. (1982) · Nature · doi:10.1038/300539a0 · Cited by 478
Research works printed but not linked: 4
- Pierce, G. B. & Fennell, R. H. in Cancer Medicine (eds Holland, J. F. & Frei, E.) 149–167 (Lea & Febiger, Philadelphia, 1982).
- Hecker, E., Fusenig, N. E., Kunz, W., Marks, F. & Thielmann, H. W. (eds) Carcinogenesis Vol. 7 (Raven, New York, 1982).
- Burns, F. J., Vanderlaan, M., Snyder, E. & Albert, R. E. Carcinogenesis Vol. 2 (eds Slaga, T. J., Sivak, A. & Boutwell, R. K.) 91–96 (Raven, New York, 1978).
- Hennings, H. et al. Cancer Res. 41, 773–779 (1981).
Cited by
Items 101–200 of 516
Molecular aspects of chemical carcinogenesis: The roles of oncogenes and tumour suppressor genes
Stanley, L. A. (1995) · Toxicology · doi:10.1016/0300-483x(94)02991-3 · Cited by 104
Yuspa, S. H., Kilkenny, A., Stanley, J. R., & Lichti, U. F. (1985) · Nature · doi:10.1038/314459a0 · Cited by 104
Cutaneous Squamous Cell Carcinoma
Parekh, V., & Seykora, J. T. (2017) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2017.06.003 · Cited by 104
Perantoni, A. O., Rice, J. M., Reed, C. D., Watatani, M., & Wenk, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6317 · Cited by 103
Widelitz, R. B., Magun, B. E., & Gerner, E. W. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.4.1088 · Cited by 100
Gilmour, S. K., Verma, A. K., Madara, T., & O’Brien, T. G. (1987) · PubMed · Cited by 100
Activation of c-myc and c-K-ras Oncogenes in Primary Rat Tumors induced by Ionizing Radiation
Sawey, M. J., Hood, A. T., Burns, F. J., & GARTE, S. J. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.932 · Cited by 99
Genetic and cellular basis of multistep carcinogenesis
Boyd, J. A., & Barrett, J. C. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90028-z · Cited by 107
Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions
Aldaz, C. M., Trono, D., Larcher, F., Slaga, T. J., & Conti, C. J. (1989) · Molecular Carcinogenesis · doi:10.1002/mc.2940020104 · Cited by 97
Oncogenes, anti-oncogenes and the immune response to cancer : a mathematical model
Sherratt, J. A., & Nowak, M. A. (1992) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1992.0071 · Cited by 99
Corominas, M., Kamino, H., León, J., & Pellicer, À. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6372 · Cited by 95
Mareel, M. M. K., Roy, F. M. V., & BAETSELIER, P. D. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00047588 · Cited by 95
Increase in mutation frequency in lung of Big Blue(R) rat by exposure to diesel exhaust
Sato, H., Sone, H., Sagai, M., Suzuki, K. T., & Aoki, Y. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.653 · Cited by 89
Progression: The Terminal Stage in Carcinogenesis
Pitot, H. C. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb01683.x · Cited by 93
Parkinson, E. K. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.219 · Cited by 93
Fox, T. R., Schumann, A. M., Watanabe, P. G., Yano, B. L., Maher, V. M., & McCormick, J. J. (1990) · PubMed · Cited by 92
Role of α Class Glutathione S-Transferases as Antioxidant Enzymes in Rodent Tissues
Yang, Y. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9450 · Cited by 91
Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Andarawewa, K. L., Boulay, A., Masson, R., Mathelin, C., Stoll, I., Tomasetto, C., Chenard, M., Gintz, M., Bellocq, J., & Rio, M. (2003) · PubMed · Cited by 104
Oncogenes in head and neck cancer
Irish, J. C., & Bernstein, A. (1993) · The Laryngoscope · doi:10.1288/00005537-199301000-00009 · Cited by 98
Greenhalgh, D. A., Welty, D. J., Player, A., & Yuspa, S. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.643 · Cited by 88
Harris, V., Coticchia, C. M., Kagan, B. L., Ahmad, S., Wellstein, A., & Riegel, A. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10802 · Cited by 85
Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants
Larizza, L., & Schirrmacher, V. (1984) · Cancer and Metastasis Reviews · doi:10.1007/bf00048385 · Cited by 84
Mutagens, oncogenes and cancer
Barbacid, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90222-2 · Cited by 84
Reichelt, J., Fürstenberger, G., & Magin, T. M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23426.x · Cited by 83
Cellular Events During Hepatocarcinogenesis In Rats And The Question Of Premalignancy
Sell, S., Hunt, J. M., Knoll, B. J., & Dunsford, H. A. (1987) · Advances in cancer research · doi:10.1016/s0065-230x(08)60690-9 · Cited by 83
Kelekar, A., & Cole, M. D. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.11.3899 · Cited by 81
Rho, O., Bol, D. K., You, J., Beltrán, L., Rupp, T., & DiGiovanni, J. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199610)17:2<78::aid-mc4>3.0.co;2-p · Cited by 27
Cayuela, M. L., Flores, J. M., & Blasco, M. A. (2005) · EMBO reports · doi:10.1038/sj.embor.7400359 · Cited by 76
Williams, A. R. W., Piris, J., Spandidos, D. A., & Wyllie, A. H. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.244 · Cited by 77
Klann, R. C., Fitzgerald, D. J., Piccoli, C., Slaga, T. J., & Yamasaki, H. (1989) · PubMed · Cited by 76
Cancer genes: rare recombinants instead of activated oncogenes (a review).
DUESBERG, P. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2117 · Cited by 76
p38δ Mitogen-Activated Protein Kinase Is Essential for Skin Tumor Development in Mice
Schindler, E. M., Hindes, A., Gribben, E. L., Burns, C. J., Yin, Y., Lin, M.-H., Owen, R. J., Longmore, G. D., Kissling, G. E., Arthur, J. S. C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4455 · Cited by 74
DoesCandidahave a role in oral epithelial neoplasia?
Field, E. A., Field, J. K., & Martin, M. V. (1989) · Medical Mycology · doi:10.1080/02681218980000391 · Cited by 75
Vousden, K. H., Eccles, S. A., Purvies, H. P., & Marshall, C. J. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910370315 · Cited by 75
León, J., Kamino, H., Steinberg, J. J., & Pellicer, À. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.786-793.1988 · Cited by 74
Role of Oncogenes and Tumor Suppressor Genes in Multistage Carcinogenesis
Yuspa, S. H., Dlugosz, A. A., Cheng, C., Denning, M. F., Tennenbaum, T., Glick, A. B., & Weinberg, W. C. (1994) · Journal of Investigative Dermatology · doi:10.1038/jid.1994.16 · Cited by 82
Stowers, S. J., Glover, P. L., Reynolds, S. H., Boone, L. R., Maronpot, R. R., & Anderson, M. W. (1987) · PubMed · Cited by 72
Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors
Escuin-Ordinas, H., Li, S., Xie, M. W., Sun, L., Hugo, W., Huang, R., Jiao, J., de‐Faria, F. M., Realegeno, S. E., Krystofinski, P. E., et al. (2016) · Nature Communications · doi:10.1038/ncomms12348 · Cited by 72
The Role of the Matrix Metalloproteinase Stromelysin in the Progression of Squamous Cell Carcinomas
Matrisian, L. M., McDonnell, S., Miller, D. B., Navre, M., Seftor, E. A., & Hendrix, M. J. C. (1991) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199109000-00008 · Cited by 70
Activated protooncogenes in human lung tumors from smokers.
Reynolds, S. H., Anna, C. K., Brown, K., Wiest, J. S., Beattie, E. J., Pero, R. W., Iglehart, J. D., & Anderson, M. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1085 · Cited by 69
Nuzum, E. O., Malkinson, A. M., & Beer, D. G. (1990) · Molecular Carcinogenesis · doi:10.1002/mc.2940030509 · Cited by 66
Normal and activated ras oncogenes and their encoded products
Levinson, A. D. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90184-8 · Cited by 67
Effects of phorbol ester on phospholipid metabolism
Kiss, Z. (1990) · Progress in Lipid Research · doi:10.1016/0163-7827(90)90001-2 · Cited by 67
Normal keratinocytes suppress early stages of neoplastic progression in stratified epithelium.
Javaherian, A., Vaccariello, M. A., Fusenig, N. E., & Garlick, J. A. (1998) · PubMed · Cited by 67
Jansen, A. P., Dreckschmidt, N. E., Verwiebe, E. G., Wheeler, D. L., Oberley, T. D., & Verma, A. K. (2001) · International Journal of Cancer · doi:10.1002/ijc.1395 · Cited by 70
Harwood, C. A., Proby, C. M., Inman, G. J., & Leigh, I. M. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2181 · Cited by 65
Transcriptional Repression of Catalase in Mouse Skin Tumor Progression
Kwei, K. A., Finch, J. S., Thompson, E. J., & Bowden, G. T. (2004) · Neoplasia · doi:10.1593/neo.04127 · Cited by 64
Self-citationA multihit, multistage model of chemical carcinogenesis
Owens, D. M., Wei, S.-J. C., & Smart, R. C. (1999) · Carcinogenesis · doi:10.1093/carcin/20.9.1837 · Cited by 64
Weyman, C. M., Taparowsky, E. J., Wolfson, M., & Ashendel, C. L. (1988) · PubMed · Cited by 64
Missero, C., Ramon y Cajal, S., & Dotto, G. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9613 · Cited by 65
Cheng, C., Kilkenny, A., Roop, D. R., & Yuspa, S. H. (1990) · Molecular Carcinogenesis · doi:10.1002/mc.2940030608 · Cited by 64
Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression
Mao, J., To, M. D., Pérez‐Losada, J., Wu, D., Rosario, R. D., & Balmain, A. (2004) · Genes & Development · doi:10.1101/gad.1213804 · Cited by 69
Self-citationCodon 12 Harvey-ras mutations are rare events in non-melanoma human skin cancer
CAMPBELL, C., Quinn, A., & Rees, J. L. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb15137.x · Cited by 73
Kerr, I. B., Lee, F. D., Quintanilla, M., & Balmain, A. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.245 · Cited by 62
Self-citationBasset‐Séguin, N., Escot, C., Molès, J., Blanchard, J. M., Kerai, C., & Guilhou, J. J. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12483807 · Cited by 61
Keyse, S. M., Amaudruz, F., & Tyrrell, R. M. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.12.5425 · Cited by 63
The role of polycyclic aromatic hydrocarbon–DNA adducts in inducing mutations in mouse skin
Chakravarti, D., Venugopal, D., Mailander, P. C., Meza, J. L., Higginbotham, S. M., Cavalieri, E. L., & Rogan, E. G. (2007) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2007.08.007 · Cited by 64
Larcher, F., Bauluz, C., Díaz‐Guerra, M., Quintanilla, M., Conti, C. J., Ballestı́n, C., & Jorcano, J. L. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940060206 · Cited by 59
Cichutek, K., & Duesberg, P. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2340 · Cited by 58
Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene
Greenhalgh, D. A., & Yuspa, S. H. (1988) · Molecular Carcinogenesis · doi:10.1002/mc.2940010209 · Cited by 58
Yamamoto, H., Ochiya, T., Takeshita, F., Toriyama‐Baba, H., Hirai, K., Sasaki, H., Sasaki, H., Sakamoto, H., Yoshida, T., Saito, I., et al. (2002) · PubMed · Cited by 65
A unified theory for the development of cancer
Spandidos, D. A. (1986) · Bioscience Reports · doi:10.1007/bf01116536 · Cited by 55
Transforming genes in human leukemia cells
Hirai, H., Tanaka, S., Azuma, M., Anraku, Y., Kobayashi, Y., Fujisawa, M., Okabe, T., Urabe, A., & Takaku, F. (1985) · Blood · doi:10.1182/blood.v66.6.1371.1371 · Cited by 54
Volpe, J. P. G. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90179-3 · Cited by 53
Harper, J. R., Roop, D. R., & Yuspa, S. H. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.9.3144-3149.1986 · Cited by 53
Targeted Disruption of Stat3 Reveals a Major Role for Follicular Stem Cells in Skin Tumor Initiation
Kim, D. J., Kataoka, K., Rao, D., Kiguchi, K., Cotsarelis, G., & DiGiovanni, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1180 · Cited by 55
Precancer in Mice: Animal Models Used to Understand, Prevent, and Treat Human Precancers
Cardiff, R. D., Anver, M. R., Boivin, G. P., Bosenberg, M., Maronpot, R. R., Molinolo, A., Nikitin, A. Y., Rehg, J. E., THOMAS, G. V., Russell, R. G., et al. (2006) · Toxicologic Pathology · doi:10.1080/01926230600930129 · Cited by 55
Lacal, J. C., & Aaronson, S. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4214 · Cited by 52
ras Oncogenes in Chemical Carcinogenesis
Sukumar, S. V. (1989) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-74700-7_3 · Cited by 53
Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death
Narayanan, K. B., Ali, M., Barclay, B. J., Cheng, Q. S., D'Abronzo, L. S., Dornetshuber-Fleiss, R., Ghosh, P., Guzman, M. J. G., Lee, T. J., Leung, P. S., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv032 · Cited by 50
Frequency of H‐ ras mutations in human bladder cancer detected by direct sequencing
Burchill, S. A., Neal, D. E., & Lunec, J. (1994) · British Journal of Urology · doi:10.1111/j.1464-410x.1994.tb07636.x · Cited by 50
Gandarillas, A., Scholl, F. G., Benito, N., Gamallo, C., & Quintanilla, M. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199709)20:1<3::aid-mc2>3.0.co;2-r · Cited by 102
Transgenic mice and squamous multistage skin carcinogenesis
Brown, K., & Balmain, A. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00665795 · Cited by 53
Self-citationWatt, F. M. (1988) · BioEssays · doi:10.1002/bies.950080509 · Cited by 55
Expression of oncogenes in human tumours with special reference to the head and neck region
Field, J. K., & Spandidos, D. A. (1987) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1987.tb01474.x · Cited by 49
Sukumar, S. V., Perantoni, A. O., Reed, C., Rice, J. M., & Wenk, M. L. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.7.2716-2720.1986 · Cited by 49
Chen, X., Makarewicz, J. M., Knauf, J. A., Johnson, L. K., & Fagin, J. A. (2014) · Oncogene · doi:10.1038/onc.2013.489 · Cited by 46
Correlated increase of the expression of the c-ras genes in chemically induced hepatocarcinomas
Corcos, D., Defer, N., Raymondjean, M., Paris, B., Corral‐Debrinski, M., Tichonicky, L., Kruh, J., Glaise, D., Saulnier, A., & Guguen‐Guillouzo, C. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)90468-6 · Cited by 48
Suzuki, J. S. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg052 · Cited by 47
McDonald, J. S., Jones, H., Pavelić, Z. P., Pavelic, L., Stambrook, P. J., Gluckman, J. L., & Pavelic, Z. R. (1994) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1994.tb00073.x · Cited by 45
Inhibition of Chemical Carcinogenesis
DiGiovanni, J. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74778-6_7 · Cited by 46
Transforming Genes and Target Cells of Murine Spleen Focus-Forming Viruses
Ostertag, W., Stocking, C., Johnson, G. R., Kluge, N., Kollek, R., Franz, T., & Hess, N. K. (1987) · Advances in cancer research · doi:10.1016/s0065-230x(08)60693-4 · Cited by 47
Becker, K., Gregel, C. M., Fricke, C., Komitowski, D. D., Dösch, J., & Kaina, B. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.541 · Cited by 43
Doi, S., Kimura, M., & Katsuki, M. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02951.x · Cited by 43
Modeling Cutaneous Squamous Carcinoma Development in the Mouse
Huang, P., & Balmain, A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013623 · Cited by 51
Self-citationRoy, F. M. V., Messiaen, L. M., Liebaut, G., Gao, J., Dragonetti, C. H., Fiers, W. C., & Mareel, M. (1986) · PubMed · Cited by 43
Tang, M., Vulimiri, S. V., Viaje, A., Chen, J. X., Bilolikar, D. S., Morris, R. J., Harvey, R. G., Slaga, T. J., & DiGiovanni, J. (2000) · PubMed · Cited by 42
Escuin-Ordinas, H., Atefi, M., Fu, Y., Cass, A., Ng, C., Huang, R. R., Yashar, S., Comin-Anduix, B., Avramis, E., Cochran, A. J., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2013.11.005 · Cited by 41
Mutations at codon 61 of the Ha‐ras proto‐oncogene in precancerous liver lesions of the B6C3F1 mouse
Buchmann, A., Mahr, J., Bauer-Hofmann, R., & Schwarz, M. (1989) · Molecular Carcinogenesis · doi:10.1002/mc.2940020303 · Cited by 42
Strategies for inhibiting multistage carcinogenesis based on signal transduction pathways
Weinstein, I. B. (1988) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(88)90202-3 · Cited by 42
Role of oncogenes in metastases
Muschel, R. J., & Liotta, L. A. (1988) · Carcinogenesis · doi:10.1093/carcin/9.5.705 · Cited by 42
Takahashi, K., Heine, U., Junker, J., Colburn, N. H., & Rice, J. M. (1986) · PubMed · Cited by 41
Milestones in Skin Carcinogenesis: The Biology of Multistage Carcinogenesis
Balmain, A., & Yuspa, S. H. (2014) · Journal of Investigative Dermatology · doi:10.1038/skinbio.2014.2 · Cited by 40
Self-citationForty years of cancer modelling in the mouse
Hirst, G. L., & Balmain, A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.013 · Cited by 43
Self-citationRamsden, M., Cole, G. E., Smith, J., & Balmain, A. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03801.x · Cited by 39
Self-citationKu, A. A., Hu, H., Zhao, X., Shah, K. N., Kongara, S., Wu, D., McCormick, F. P., Balmain, A., & Bandyopadhyay, S. (2020) · Nature Communications · doi:10.1038/s41467-020-16078-y · Cited by 40
Self-citationLatent Viruses and Mutated Oncogenes: No Evidence for Pathogenicity
DUESBERG, P. H., & Schwarz, J. R. (1992) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)61047-8 · Cited by 38
Understanding the Pathogenesis of Recessive Dystrophic Epidermolysis Bullosa Squamous Cell Carcinoma
South, A. P., & O’Toole, E. A. (2009) · Dermatologic Clinics · doi:10.1016/j.det.2009.10.023 · Cited by 37
Jhappan, C., Takayama, H., Dickson, R. B., & Merlino, G. T. (1994) · PubMed · Cited by 37
Compere, S. J., Baldacci, P., & Jaenisch, R. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90008-x · Cited by 37
Metadata
- Authors
- Balmain, A., Ramsden, M., Bowden, G. T., & Smith, J.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- ORCID
- Balmain, Allan
- Venue
- Nature
- Published
- 1984-02
- Volume
- 307
- Issue
- 5952
- Pages
- 658-660
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015936619
- Cited by
- 529
- References
- 19
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 5 · 2015: 16 · 2014: 5 · 2013: 9 · 2012: 9
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- skin papilloma, chemical carcinogenesis, precancerous lesions, proto-oncogene activation, transforming activity, gene expression, epidermis
- MeSH terms
- Proto-Oncogene Mas, Animals, Cell Transformation, Neoplastic, Gene Expression Regulation, Oncogenes, Papilloma, Skin Neoplasms, Transcription, Genetic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.